Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
Neuroinflammation in Alzheimer's disease
Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the
neuronal compartment, but includes strong interactions with immunological mechanisms in …
neuronal compartment, but includes strong interactions with immunological mechanisms in …
Immune attack: the role of inflammation in Alzheimer disease
The past two decades of research into the pathogenesis of Alzheimer disease (AD) have
been driven largely by the amyloid hypothesis; the neuroinflammation that is associated with …
been driven largely by the amyloid hypothesis; the neuroinflammation that is associated with …
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models
The goal of this review is to discuss how behavioral tests in mice relate to the pathological
and neuropsychological features seen in human Alzheimer's disease (AD), and present a …
and neuropsychological features seen in human Alzheimer's disease (AD), and present a …
The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease
Alzheimer's disease (AD) is neuropathologically characterized by the intracellular
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …
Long road to ruin: noradrenergic dysfunction in neurodegenerative disease
D Weinshenker - Trends in neurosciences, 2018 - cell.com
It has been known for decades that degeneration of the locus coeruleus (LC), the major
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …
Targeting neuroinflammation to treat Alzheimer's disease
A Ardura-Fabregat, E Boddeke, A Boza-Serrano… - CNS drugs, 2017 - Springer
Over the past few decades, research on Alzheimer's disease (AD) has focused on
pathomechanisms linked to two of the major pathological hallmarks of extracellular …
pathomechanisms linked to two of the major pathological hallmarks of extracellular …
Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology
F Kosel, JMS Pelley, TB Franklin - Neuroscience & Biobehavioral Reviews, 2020 - Elsevier
Transgenic mouse models have been used extensively to model the cognitive impairments
arising from Alzheimer's disease (AD)-related pathology. However, less is known about the …
arising from Alzheimer's disease (AD)-related pathology. However, less is known about the …
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine
Locus ceruleus (LC)-supplied norepinephrine (NE) suppresses neuroinflammation in the
brain. To elucidate the effect of LC degeneration and subsequent NE deficiency on …
brain. To elucidate the effect of LC degeneration and subsequent NE deficiency on …
Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease
JM Rorabaugh, T Chalermpalanupap, CA Botz-Zapp… - Brain, 2017 - academic.oup.com
Abstract See Grinberg and Heinsen (doi: 10.1093/brain/awx261) for a scientific commentary
on this article. Clinical evidence suggests that aberrant tau accumulation in the locus …
on this article. Clinical evidence suggests that aberrant tau accumulation in the locus …